PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 201 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2015. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $1,000 | -97.3% | 100 | -90.0% | 0.00% | -97.7% |
| Q1 2017 | $37,000 | +19.4% | 1,000 | 0.0% | 0.04% | +22.9% |
| Q4 2016 | $31,000 | +3.3% | 1,000 | 0.0% | 0.04% | +2.9% |
| Q3 2016 | $30,000 | 0.0% | 1,000 | 0.0% | 0.03% | 0.0% |
| Q2 2016 | $30,000 | +3.4% | 1,000 | 0.0% | 0.03% | +3.0% |
| Q1 2016 | $29,000 | -62.8% | 1,000 | 0.0% | 0.03% | -52.2% |
| Q4 2015 | $78,000 | +4.0% | 1,000 | 0.0% | 0.07% | +11.3% |
| Q3 2015 | $75,000 | -35.9% | 1,000 | 0.0% | 0.06% | -32.6% |
| Q2 2015 | $117,000 | -50.4% | 1,000 | 0.0% | 0.09% | -45.2% |
| Q1 2015 | $236,000 | +24.9% | 1,000 | 0.0% | 0.17% | +14.3% |
| Q4 2014 | $189,000 | -20.9% | 1,000 | 0.0% | 0.15% | -19.7% |
| Q3 2014 | $239,000 | +262.1% | 1,000 | 0.0% | 0.18% | +258.8% |
| Q2 2014 | $66,000 | – | 1,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $4,713,260 | 4.15% |
| Eversept Partners, LP | 1,681,149 | $4,421,422 | 0.37% |
| Camber Capital Management LP | 4,235,000 | $11,138 | 0.37% |
| Kynam Capital Management, LP | 473,975 | $1,246,554 | 0.20% |
| GLOBEFLEX CAPITAL L P | 538,559 | $1,416,410 | 0.17% |
| Affinity Asset Advisors, LLC | 202,349 | $532,178 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 279,629 | $735 | 0.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 363,666 | $956,442 | 0.06% |
| Patriot Financial Group Insurance Agency, LLC | 67,000 | $176,210 | 0.04% |
| ACADIAN ASSET MANAGEMENT LLC | 1,858,000 | $4,884 | 0.02% |